As of 2024-12-05, the Relative Valuation of Eagle Pharmaceuticals Inc (EGRX) is 146.45 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.14 USD, the upside of Eagle Pharmaceuticals Inc based on Relative Valuation is 6743.3%.
The range of the Relative Valuation is 70.15 - 211.92 USD.
| Range | Selected | |
| Trailing P/E multiples | 25.0x - 37.5x | 35.9x |
| Forward P/E multiples | 25.2x - 36.5x | 33.1x |
| Fair Price | 70.15 - 211.92 | 146.45 |
| Upside | 3178.0% - 9803.0% | 6743.3% |
| Date | P/E |
| 2024-11-29 | 0.25 |
| 2024-11-27 | 0.25 |
| 2024-11-26 | 0.34 |
| 2024-11-25 | 0.30 |
| 2024-11-22 | 0.34 |
| 2024-11-21 | 0.32 |
| 2024-11-20 | 0.23 |
| 2024-11-19 | 0.23 |
| 2024-11-18 | 0.32 |
| 2024-11-15 | 0.23 |
| 2024-11-14 | 0.25 |
| 2024-11-13 | 0.27 |
| 2024-11-12 | 0.32 |
| 2024-11-11 | 0.30 |
| 2024-11-08 | 0.30 |
| 2024-11-07 | 0.30 |
| 2024-11-06 | 0.28 |
| 2024-11-05 | 0.28 |
| 2024-11-04 | 0.18 |
| 2024-11-01 | 0.20 |
| 2024-10-31 | 0.21 |
| 2024-10-30 | 0.18 |
| 2024-10-29 | 0.14 |
| 2024-10-28 | 0.12 |
| 2024-10-25 | 0.21 |
| 2024-10-24 | 0.23 |
| 2024-10-23 | 0.23 |
| 2024-10-22 | 0.25 |
| 2024-10-21 | 0.25 |
| 2024-10-18 | 0.32 |
| 2024-10-17 | 0.23 |
| 2024-10-16 | 0.28 |
| 2024-10-15 | 0.21 |
| 2024-10-14 | 0.21 |
| 2024-10-11 | 0.31 |
| 2024-10-10 | 0.21 |
| 2024-10-09 | 0.33 |
| 2024-10-08 | 0.20 |
| 2024-10-07 | 0.23 |
| 2024-10-04 | 0.32 |
| 2024-10-03 | 0.71 |
| 2024-10-02 | 0.76 |
| 2024-10-01 | 1.27 |
| 2024-09-30 | 1.33 |
| 2024-09-27 | 1.41 |
| 2024-09-26 | 1.45 |
| 2024-09-25 | 1.38 |
| 2024-09-24 | 1.39 |
| 2024-09-23 | 1.39 |
| 2024-09-20 | 1.41 |